Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753479 · ClinicalTrials.gov registry record · NA
Spectroscopy From Duodenum
A NA study of Pancreatic Adenocarcinoma, sponsored by Olympus Corporation.
- Completed
- Registry status
- NA
- Development phase
- 445
- Enrollment target
- 4
- Study locations
NCT01753479 is a NA study of Pancreatic Adenocarcinoma that has completed, run by Olympus Corporation. The registered enrollment target is 445 participants, below the 99,458-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01753479, a NA study of Pancreatic Adenocarcinoma, has completed, sponsored by Olympus Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 445 participants
- Enrollment target
- 4
- Study locations
Study Summary
Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.
Conditions Studied
Interventions
- OTHER Spectroscopy device
Study Locations (4)
Florida
- Mayo Clinic Florida - Jacksonville
Texas
- The University of Texas M. D. Anderson Cancer Center - Houston
Brussels Capital
- Hôpital Erasme - Brussels
Lazio
- Università Cattolica del Sacro Cuore - Rome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753479
The ClinicalTrials.gov registry entry for NCT01753479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99,458-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The listed sponsor is Olympus Corporation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Spectroscopy device is the first listed.
NCT01753479 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Texas, Brussels Capital.
Frequently Asked Questions
What is clinical trial NCT01753479 about?
NCT01753479 is a clinical study titled "Spectroscopy From Duodenum". Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.
What is the current status of trial NCT01753479?
This trial is currently completed. It is a NA study. The enrollment target is 445 participants. The study started on 2013-01. Estimated completion is 2016-06-30.
What conditions does trial NCT01753479 study?
This clinical trial studies the following conditions: Pancreatic Adenocarcinoma.
What interventions are being tested in trial NCT01753479?
The interventions under investigation include: Spectroscopy device (OTHER).
Who is sponsoring clinical trial NCT01753479?
This trial is sponsored by Olympus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01753479 being conducted?
This trial has 4 study locations across Florida, Texas, Brussels Capital, Lazio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
RECRUITING · NA
-
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
ACTIVE NOT RECRUITING · NA
-
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
COMPLETED · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.